Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Non-Current Deferred Tax Liability: 2015-2021

Historic Non-Current Deferred Tax Liability for Aytu Biopharma (AYTU) over the last 1 years, with Dec 2021 value amounting to $100,000.

  • Aytu Biopharma's Non-Current Deferred Tax Liability was N/A to $100,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $100,000, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2021, which is N/A change from last year.
  • According to the latest figures from Q4 2021, Aytu Biopharma's Non-Current Deferred Tax Liability is $100,000, which was down 0.00% from $100,000 recorded in Q3 2021.
  • Aytu Biopharma's Non-Current Deferred Tax Liability's 5-year high stood at $200,000 during Q2 2021, with a 5-year trough of $100,000 in Q3 2021.
  • For the 1-year period, Aytu Biopharma's Non-Current Deferred Tax Liability averaged around $133,333, with its median value being $100,000 (2021).